Best Myeloma doctors in Germany: TOP 6 doctors

• Dr. Elke Jaeger specializes in Myeloma treatment with 35+ years of experience.
• Utilizes stem cell transplantation, chemotherapy, and targeted therapy for Myeloma.
• Recognized as a top sarcoma specialist, also adept in Myeloma care.
• Head physician at a leading Oncology and Hematology Center in Germany.
• Ranked among the best German oncologists by the Focus rating.
• Provides online consultations for patients with Myeloma.
• Fluent in both German and English, ensuring clear communication.

• Dr. Eckhart Weidemann specializes in advanced Myeloma treatment.
• Utilizes chemotherapy, stem cell transplant, and targeted therapy for Myeloma.
• International practice in Germany and research collaborations worldwide.
• Holds vital hematology certifications, ensuring expert care.
• Member of esteemed hematology and oncology societies.
• Offers online consultations for Myeloma patients globally.
• Fluent in German and English, facilitating diverse patient communication.

• Dr. Bernd Hertenstein focuses on Myeloma treatment with 32 years of experience.
• Expert in chemotherapy, stem cell transplantation, and precision-targeted therapy.
• Utilizes treatment approaches: immunotherapy, bisphosphonates, and radiation therapy.
• International practice in countries such as Germany, USA, and Switzerland.
• Holds accreditation for his expertise in Clinical Oncology.
• Member of various prestigious oncological societies, ensuring updated practices.
• Consults patients online, offering convenience for Myeloma sufferers.
• Fluent in German and English, facilitating clear communication with patients.

Membership in societies:

German Society of Oncology and Haemato-oncology GDHO
German Association of Physicians

American Association for Cancer Research

Expert in scientific journals 

Close collaboration with leading haematologists 

Involved in molecular biology research on the treatment of haemato-oncological diseases

Specialization:

Comprehensive treatment of tumour diseases, in particular chemotherapy, immunotherapy, immunotherapy, targeted therapy, radiation therapy molecular diagnostics.

Work experience:

2006: Graduation from the Faculty of Medicine of the University of Köln

2011: Specialization ‘Haematologist, Oncologist and Immunologist’

2011: Deputy Chief Physician of the Pulmonology Clinic Köln, Haematologist, Oncologist and Immunologist. Cologne, Haemato-oncologist and senior palliative care physician

2016: Qualification as a specialist in genetics

2021: Chief Physician of the Clinic for Haematology, Oncology and Palliative Care at the certified interdisciplinary cancer centre BKZ Solingen.

Dr. Fox is also actively involved in molecular biology research to develop and implement innovative treatments for haemato-oncological diseases. Her scientific work in this area has contributed to significant advances in understanding the molecular mechanisms of cancer and the development of effective therapies.

Dr. Fox specializes in the comprehensive treatment of tumour diseases, including chemotherapy, immunotherapy, targeted therapies, radiation therapy and molecular diagnostics.

Throughout her career, Dr. Fox has proven herself to be an outstanding specialist, constantly innovating treatment methods and approaches. Her patients receive the most effective and state-of-the-art treatments, which has earned her recognition and respect amongst colleagues and patients alike.

She completed her training at the Charité in Berlin and has been a specialist in radiotherapy for 20 years. She worked as a senior physician in all departments of the Charité in Berlin, and from 2007 to 2015 she was a senior physician and deputy director of the Charité clinic in Berlin. In 2015, she was appointed head of the department of radiotherapy at the University Hospital of Cologne and very successfully headed the clinic there until 2022. Since the end of 2022, she has been heading the private radiotherapy clinic "RadioOnkologie Vosspalais". Clinical areas include radioimmunotherapy, high-precision therapy, multimodal therapy of gynecological tumors and prostate carcinoma.

Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Professor Dr. Marnitz is a member of the German and European Guidelines for the Therapy of Endometrial Carcinoma. She is also an independent external expert of the European Council for the Therapy of Carcinoma of the Cervical, Vulvar and Vaginal Cancer. Several randomized clinical trials have been conducted under her leadership.

Professor Dr. Marnitz is an honorary member of the Russian Society of Gynecological Oncology, a member of the professional societies DEGRO, ESTRO, ASTRO. In 2024, Professor Dr. Marnitz will be the president of the congress of the annual conference of the German Society of Radiation Oncology.